Friday, October 09, 2026

 

From a single cell to 1.2 million: Scientists successfully create the largest cellular “family tree” for a mammal



The new findings could provide valuable insights into birth defects and cancer



Allen Institute

Lineage Tree

image: 

A circular lineage tree of a 13-day old mouse embryo, originating from a single cell at the center expanding outward over developmental time. Cells derived from the first cell division are marked in blue or red.

view more 

Credit: Seattle Hub for Synthetic Biology






How does a single fertilized egg produce all the cells in an animal’s body? This question has hung over science for decades, and it’s critical to understanding how diseases like cancer take hold and spread in the body. A new study in the journal Science led by researchers from the Seattle Hub for Synthetic Biology (Seattle Hub)—comprised of the Allen Institute, UW Medicine, and Biohub—moves us closer to the answer.

Researchers successfully built a time-calibrated lineage tree showing how a single cell turned into 1.28 million—about 10% of the cells in a two-week-old mouse embryo. This is by far the largest lineage tree ever built for a mammal.

“This work brings us closer to understanding one of biology’s fundamental questions on how a single cell gives rise to the extraordinary complexity of a living organism,” said Garabet Yeretssian, director of extramural research and partnerships at Biohub, which has provided ongoing funding for the Seattle Hub. “We are proud to support the Seattle Hub team in developing technologies that make it possible to trace that process at an unprecedented scale and open new ways to understand how those trajectories change during development and disease."

Scientists used a technology called DNA Typewriter to reconstruct most of the cell lineage of a developing mouse, mapping how more than 1.28 million individual cells emerged from the first cell division to form tissues and organs. Their research could provide crucial insights into understanding birth defects and even cancer.

DNA Typewriter works by inserting sequential genetic stamps into a cell’s DNA as it divides. The stamps are copied into every daughter cell—a cell that results when a parent cell divides—and written in order, so they act like a journal within the genome, revealing how a cell divided and what happened to it when it did. Researchers injected the DNA Typewriter system into a fertilized mouse egg and let the embryo develop for 13.5 days, around two-thirds of the way through mouse gestation. They measured the genetic stamps in 1.58 million individual cell nuclei and reconstructed the “family tree” of cells composing the embryo.

"We were surprised by just how robustly marking happened right at the very first division," said Haedong Kim, co-first author of the study. "It gave us two naturally occurring, independent copies of the same experiment, within a single embryo, so we could check every finding twice."

Researchers identified multiple unique marks—genetic fingerprints that help scientists distinguish one cell from another—written by DNA Typewriter at the first cell division, when the fertilized egg split into two cells. And as they in turn continued to divide into more cells on two parallel but different tracks, researchers found that they contributed a different number of total cells to the embryo—about 57% to 42%—but provided the same proportion of every cell type.

“Our success in putting DNA Typewriter into a developing embryo, together with the resulting cell lineage, brings us closer to our dream of comprehensively mapping mammalian development,” said Jay Shendure, scientific director of the Seattle Hub for Synthetic Biology and professor of genome sciences at UW Medicine. “All cell types have their origins in development, and such maps may enable insights into the thousands of genetic disorders that arise during development.”

 

What this means for human health

 

This research is a critical first step because learning how cells divide and organize during development could help researchers better understand birth defects, cancer, and developmental disorders. By understanding the path of normal cellular development and how one cell becomes many, researchers have a reference model for comparison that can better identify when and where the normal path diverges into diseases. This knowledge can help researchers develop ways to prevent abnormal cellular development or intervene when cells go astray.

The DNA Typewriter technology could also be applied to determine how cancer cells spread, better understand how stem cell therapies work, and how aging affects cells in various organs. Recovering biological answers from lineage data could accelerate research that might otherwise take much longer.

Importantly, this study shows that it’s possible to record and read a dense cell lineage history of a complex mammal in a single experiment. The DNA Typewriter system embedded ordered molecular marks throughout mouse development that could be decoded to reconstruct which cell gave rise to which. The resulting tree is publicly available, along with an interactive browser called NextCell that allows anyone to explore this cellular family tree of mouse development.

 

About Allen Institute

Allen Institute is a 501(c)(3) nonprofit medical research organization dedicated to accelerating science for a healthier world. Through large-scale, multidisciplinary research initiatives, the Institute generates foundational knowledge, data, tools, and models that are shared openly with the world to advance our understanding of life and health. Founded by Jody Allen and the late Paul G. Allen, Allen Institute is supported primarily by Fund for Science and Technology. 

— 30 —


Zoom Out [VIDEO] 


The cell lineage of a mouse embryo, from the fertilized egg to day 13.5 of development: 1,281,141 cells from one animal. The embryo recorded its own cell divisions in its genome as it developed, using a molecular recorder called DNA Typewriter. Distance from the center is developmental time, so pulling back is the same as running the clock forward.

 

Polynesian wayfinding is written in the genomes of island populations



UC San Diego research reveals how Polynesian seafaring shaped the genomes of island populations, offering new clues to health risks and medical discoveries in rarely studied communities




University of California - San Diego






For centuries, Polynesian navigators crossed thousands of miles of open ocean, using their knowledge of stars, currents, birds, clouds and the sea to settle islands across the Pacific. Now, a new University of California San Diego study shows the history of voyaging is also reflected in the genomes of Polynesian populations today.

Published Oct. 8 in Science and featured on the journal’s cover, the study analyzes whole-genome sequences from 1,050 individuals across Polynesia. The findings offer genomic evidence of the extraordinary skill, knowledge and achievement of Polynesian voyagers, whose mastery of long-distance ocean travel helped shape the genetic history of the Pacific. 

Using DNA to trace how Polynesian communities were formed, the study also shows that the same migration history may help explain why certain health-related genetic variants are more common in some island populations.

As Polynesian voyagers left established island communities to settle new ones, each group carried only a portion of the genetic diversity found in the population it left behind. For example, a group departing Mangareva for HawaiÊ»i or Rapa Nui would have carried only a smaller genetic selection of the people living in Mangareva. When later groups set out from newly settled islands, they carried an even smaller subset of that genetic variation with them. 

The authors compare the pattern to a set of Russian nesting dolls: The largest population contains the most genetic variation, while each successive population contains a smaller genetic subset within it.

“As we go from one island to the next, we're selecting a subset of a gene pool, and that is shaping our genome over time,” said Keolu Fox, an associate professor of anthropology at the UC San Diego School of Social Sciences and a corresponding author of the study.

Reconstructing a history of voyaging

The study examined genomic data from populations in French Polynesia, including the Austral, Society, Marquesas and Tuamotu islands, as well as Mangareva. The researchers also incorporated data from Rapa Nui, Native Hawaiians, Samoans and Tongans.

The analysis found that HawaiÊ»i and Rapa Nu i — two of the most geographically distant Polynesian populations — are also the most closely genetically related among the remote island populations studied.

The islands are separated by approximately 7,000 kilometers and each is more than 3,000 kilometers from the nearest inhabited Polynesian island. The researchers say their genetic similarities suggest that both populations were ultimately settled by voyagers whose deeper ancestral roots trace back to Mangareva.

The findings support the existence of an ancient culture capable of repeated, long-distance voyaging across the Pacific. The researchers refer to this hypothesized tradition as Holomoana Nui, meaning “great ocean voyaging.”

The pattern was not created by a single, one-way migration. Polynesian voyaging involved repeated movement among island populations, with voyagers carrying provisions, knowledge and genetic material across the ocean. Over time, the repeated settlement of new islands produced increasingly concentrated founder effects.

In Polynesia, the researchers found evidence of multiple founder effects — when small groups establish new populations, carrying only a portion of the genetic diversity of the larger population they left behind. They also discovered bottlenecks — when disease or another major event sharply reduces a population, leaving survivors with less genetic variation than before — accumulating over the course of settlement. The result is one of the strongest cumulative founder effects observed in human population genetics.

What the findings could mean for health

Founder effects can influence health because rare genetic variants carried by a small founding population may become more common in later generations.

The researchers identified three variants associated with autosomal recessive diseases at relatively high frequencies in French Polynesia. One variant in the FAN1 gene, associated with karyomegalic interstitial nephritis — a rare condition that can lead to kidney failure — was found in more than 11% of the French Polynesian cohort. The variant was absent from gnomAD, a major international database containing genomic data from more than 800,000 individuals.

The findings demonstrate how medically important variants can be common within a specific founder population while remaining invisible in large global genomic databases.

That gap matters because much of modern genomic medicine has been developed using data from populations of European ancestry. Without more detailed information about Polynesian populations, clinicians may not know which variants to screen for or how frequently certain disease-associated variants occur.

The study also underscores why broad population categories can be inadequate for clinical genetics. Grouping Native Hawaiian and Pacific Islander populations together may obscure important differences among individual island populations.

Fox said the findings could eventually help researchers develop more precise approaches to screening, diagnosis and treatment, including for diseases such as cancer.

The study itself does not establish new clinical guidelines or treatments. Rather, it identifies genetic information that could guide future research and clinical work.

A study designed around trust

Fox, who is the first Native Hawaiian to earn a Ph.D. in Genome Sciences, has a longstanding interest in Polynesian history and the health needs of Pacific Islander communities.

During a 2017 visit to French Polynesia, a conversation about the legacy of French nuclear testing led Fox to consider how genomic research might help clarify disease risks in communities exposed to environmental hazards and underserved by modern medical infrastructure.

The French government conducted 193 nuclear tests in French Polynesia between 1966 and 1996. Fox said the experience prompted him to think more deeply about how precision medicine could serve communities that have not always had access to comprehensive cancer screening, genetic testing or specialized care.

But the study was also shaped by a second question: How could the research be conducted in a way that protected Indigenous communities and allowed them to share in the benefits of scientific discovery?

The answer became Variant Bio, a biotechnology company that Fox joined as a senior advisor while conducting the research. It develops partnerships with populations that have historically been underrepresented in genomic research. He said the company was created to give participating communities greater control over how their data are collected, stored and used.

“We want to build trust first,” Fox said. “Making you a partner and not a subject in this allows us to expedite the development of these projects.”

That approach treats community members as partners in research rather than simply as sources of biological material. It includes explaining the potential uses and risks of genomic data, building relationships with community leaders and involving local health professionals in the research process.

The study includes contributions from Indigenous and Pacific Islander communities in Hawaiʻi, Rapa Nui and French Polynesia. Its authors also acknowledge the French Polynesian clinicians, nurses and community health workers who helped make the research possible.

Fox said the inclusion of local clinicians reflects a central principle of the project: The people who understand the health needs of a community should be involved in research conducted there.

“None of this is possible without the contributions of these partners,” Fox said.

Sharing in the benefits

Variant Bio’s model includes a formal benefit-sharing commitment of 4% of the company’s revenue and 4% of equity-derived value that are designated for partner communities.

The arrangement is intended to ensure that communities contributing genetic data share in the value created by research and future commercial partnerships. The funds can support priorities identified by the communities themselves, including health care, education, infrastructure, food sovereignty, energy projects and data infrastructure.

For Fox, benefit-sharing is not separate from the science. It is part of the research design.

“If you want to recruit communities into research, you have to make them stakeholders in the technology you are building,” he said.

Fox, who spent nearly a decade on the research endeavor, says the paper in Science reflects a broader vision for the future of genomic medicine — one in which Indigenous communities help shape the research questions, govern the use of their data and participate in the benefits of discoveries made from their genomes.

“It is remarkable to say that our achievements as voyaging people have shaped our genomes over time,” Fox said. “And to have that recognized on the cover of Science is incredibly validating.” 

Read the full study, “Message in a Bottleneck: Nested Founder Effects from French Polynesia to Rapa Nui and HawaiÊ»i” in Science. 

 

Study finds positive parenting teaches children how to experience joy—and could lead to better mental health



By Tracy DeStazio




University of Notre Dame

Kaylin Hill

image: 

Kaylin Hill is an assistant professor in Notre Dame’s Department of Psychology and a faculty affiliate with the Shaw Center for Children and Families and Eck Institute for Global Health. She also directs the PAL Lab, where she and her team seek to understand what makes individuals vulnerable to mental health issues and how best to intervene.

view more 

Credit: University of Notre Dame






More than one in five adults in the US experience mental illness each year, according to data from the National Alliance on Mental Illness. And more than one in seven young people ages 6–17 experience a mental health disorder, with 50 percent of all mental illness occurring throughout one’s lifetime beginning by age 14 and 75 percent by age 24.

Psychologists have long espoused that how parents raise their children during their early years of life has a huge impact on their mental health and happiness as they grow up. Something as simple as praising or scolding a child can be deeply internalized and could determine whether or not that child struggles with depression, anxiety, or substance use as a teenager or young adult.

But how and where the connection is made between parenting behaviors and future susceptibility to a mental health disorder is harder to discern. Notre Dame psychologist Kaylin Hill has devoted the past 15 years of her career to better understanding emotions and depression—and how to break the cycle of intergenerational mental health issues.

Hill, an assistant professor in Notre Dame’s Department of Psychology, has found that parents’ child-rearing methods during the preschool years coincide with how that child experiences joy and satisfaction across adolescence—a period during which the risk for mental health issues is at its highest. Her research was recently published in Communications Psychology, part of the Nature journal suite of publications.

“In this project, we demonstrate that early parenting is associated with one of the largest neural indicators of risk for mental health concerns we know of to date,” said Hill, a clinical psychologist and faculty affiliate with Notre Dame’s Shaw Center for Children and Families and Eck Institute for Global Health.

Hill focuses her work on how to reduce the burden and strain of depression on individuals and families; and through her directorship of Notre Dame’s Psychophysiology of Affect across the Lifespan (PAL) Lab, she seeks to understand what makes those individuals vulnerable in the first place and how best to intervene.

Finding the common thread between behaviors and future susceptibility

Hill and her research team began their work by observing the one-on-one interactions and parenting behavior between 3-year-old children and their parents. They then compared that data to the development of neural reward responsiveness—how the brain responds to rewards or positive stimuli—of those same children at ages 9, 12, 15, and 18. This longitudinal study spanned 15 years and included 465 young people and their parents at Stony Brook University in New York, and was supported by a grant from the National Institute of Mental Health.

Previous research has shown that adequate reward processing in the brain is necessary for adolescents and adults to experience joy, excitement, and pleasure—a phenomenon that can even be seen in early childhood.

“This study is really the first of its kind that measures what early life experiences are associated with reward processing from childhood through late adolescence or early adulthood,” Hill said. “And reward processing seems to be one of those pieces to the puzzle of what may put us at risk for developing mental disorders. Being able to observe reward processing, and how it develops from ages 9 to 18, is really helpful to understanding depression risk.”

When watching the 3-year-old children and their parents interact in the laboratory at the start of the study, Hill and her team coded how often they saw positive parenting behaviors (displaying warmth, support, and encouragement) versus negative parenting behaviors (being harsh, heavy-handed, or overly intrusive).

Those coded interactions were compared to the data recorded from the brain’s responses to rewarding stimuli. With an electroencephalogram (EEG), which uses small electrodes attached to the scalp through a cap to record the brain’s electrical activity, the scientists were able to track reward processing at the brain level.

In this study, the researchers used money as the reward for winning a guessing game, which allowed them to look at the brain’s electrical signals in response to a win versus a loss. Because the EEG system is adaptable to a range of individuals across abilities and cognitive stages, the scientists were able to assess reward processing at the brain level beginning at age 9 and followed up at ages 12, 15, and 18.

Their findings indicated that the children who experienced higher levels of positive parenting got more excited about winning the money, while the children raised with a more negative parenting style were less enthusiastic.

“What we saw is that the more positive, and less negative, parenting behaviors we observed at age 3, the larger the brain’s reward response seemed to be for individuals across adolescence,” Hill said.

In other words, the more praise and affirmation children receive from their parents at a young age, the better they are at recognizing the joyful things in life. The work of Hill and her team demonstrated that positive parenting experienced in the early years may teach children’s brains how to respond to good things—fun activities, friendships, success, and well-being.

On the flip side, if a parent is particularly harsh or intrusive, that child’s brain may develop a low reward response—a difficulty experiencing pleasure and happiness that subsequently opens the door to sadness and despondency.

“Experiencing positive parenting seems to help facilitate reward processing, which is important for promoting physical and mental health,” added Hill, who is also a faculty affiliate with Notre Dame’s Neuroscience and Behavior program and its Human Neuroimaging Center.

Discoveries point toward possibility of early intervention

The study’s findings point to an opportunity for intervention, which Hill believes may need to include parents and children. She says it is critical to support parents—perhaps even before their child is born—as well as children and adolescents, in order to address the series of events from parent behaviors observed at age 3 to child development from ages 3 to 18. She notes that while this study was observational, it gives important clues for how experiences and development may unfold over time.

Current research indicates that the most reliable and prominent predictor of depression is family history, paired with the experience of a stressful life event. According to Hill, this study opens up a world of possibilities in terms of what intervention could look like. “There’s something very important about early parent-child interactions and parenting behaviors,” she said. “And I love that because behaviors are so much more open to intervention than a genetic explanation to what is driving risk within families.”

Hill and her team hope their work can inform a broader conversation about how to prevent depression, one of the most prevalent and debilitating mental disorders. “We are trying to pull together a single strand—one explanation of likely many that exists—of what puts someone at risk and how we can intervene,” she said.

Contact: Erin Blasko, director of media engagement, 574-631-4127, eblasko@nd.edu